This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Phases of acute pancreatitis

Authoring team

phases of acute pancreatitis

Two overlapping phases with two peaks of mortality can be identified in acute pancreatitis:

  • early phase
    • present during the first week (but may extend to the second week as well)

    • host response to local pancreatic injury will result in systemic disturbances which will clinically manifest as the systemic inflammatory response syndrome (SIRS)
      • SIRS - defined by presence of two or more criteria:
        • heart rate >90 beats/min
        • core temperature <36°C or >38°C
        • white blood count <4000 or >12000/mm3
        • respirations >20/min or PCO2 <32mmHg

    • the severity of acute pancreatitis during early phase is determined by the presence and duration of organ failure
      • persistent SIRS (>48 hours) has been shown to be strongly associated with subsequent risk of developing organ failure

    • local complications may be present but does not influence the severity of the condition

  • late phase
    • characterised by the continuation of systemic signs of inflammation or by the presence of local complications
    • seen only in patients with moderately severe or severe acute pancreatitis (1,2)

Reference:


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.